ABB joins forces with Ferrari Hypersail to take Direct Current to new horizons

Zurich, Switzerland, Sept. 14, 2026 (GLOBE NEWSWIRE) —

ABB today announces a technology partnership with Ferrari Hypersail that brings ABB’s electrification expertise to the world’s most ambitious offshore challenge. As Electrification Partner, ABB will support the challenge with expertise across marine power, Direct Current (DC) technology and advanced electrical systems.  

Update on Scheme of Arrangement

TORONTO and PERTH, Western Australia, Sept. 14, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) refers to the proposed transaction under which Central Asia Metals PLC (AIM: CAML) (“CAML”) will acquire 100% of the shares in Cygnus pursuant to a scheme of arrangement under Part 5.1 of the Corporations Act 2001 (Cth) (“Scheme”).

The GLP-1 Boom Is Bypassing Latino Patients; Bilingual Telehealth Clinic Sol y Vida Launches to Change That

— Latino-founded, LegitScript-certified clinic opens for Hispanic Heritage Month with licensed clinicians, published prices and care in Spanish — “recetado, no comprado” —

— Latino-founded, LegitScript-certified clinic opens for Hispanic Heritage Month with licensed clinicians, published prices and care in Spanish — “recetado, no comprado” —

Eastern International Ltd. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

HANGZHOU, China, Sept. 11, 2026 (GLOBE NEWSWIRE) — Eastern International Ltd. (“Eastern International” or the “Company”) (NASDAQ: ELOG), a provider of domestic and cross-border professional logistic services and construction services including project logistic, general logistic and new energy infrastructure construction, today announced that, on September 10, 2026, the Company received a letter from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s ordinary shares listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer meets the minimum bid price requirement for continued listing on Nasdaq under Nasdaq Marketplace Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”).

Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)

HOUSTON, Sept. 11, 2026 (GLOBE NEWSWIRE) — Impact BioMedical Inc. (the “Company”) today announced that the Company’s Board of Directors has approved a 1 for 12.62 reverse stock split of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock“). The reverse stock split will become effective at 12:01 a.m., Eastern Time, on September 23, 2026. Starting with the opening of trading on that date, the Company’s Common Stock will continue to trade on the NYSE American Exchange under the ticker symbol “IBO” and will trade under a new CUSIP number to be assigned in connection with the reverse stock split.